603658 安图生物
已收盘 09-04 15:00:00
资讯
新帖
简况
股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》
证券之星 · 01:21
股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》
每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围
证券之星 · 09-06 02:57
每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围
安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%
证券之星 · 09-04 17:41
安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%
股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》
证券之星 · 08-31
股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》
每周股票复盘:安图生物(603658)股东户数降7.09%
证券之星 · 08-30
每周股票复盘:安图生物(603658)股东户数降7.09%
股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%
证券之星 · 08-26
股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%
安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%
证券之星 · 08-25
安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%
国金证券:给予安图生物买入评级
证券之星 · 08-25
国金证券:给予安图生物买入评级
图解安图生物中报:第二季度单季净利润同比下降13.43%
证券之星 · 08-25
图解安图生物中报:第二季度单季净利润同比下降13.43%
安图生物(603658)披露2026年半年度报告,8月24日股价下跌1.5%
证券之星 · 08-24
安图生物(603658)披露2026年半年度报告,8月24日股价下跌1.5%
每周股票复盘:安图生物(603658)募集资金现金管理赎回17,298.08万元
证券之星 · 08-23
每周股票复盘:安图生物(603658)募集资金现金管理赎回17,298.08万元
股市必读:安图生物新发布《安图生物关于使用闲置募集资金进行现金管理赎回及进展的公告》
证券之星 · 08-19
股市必读:安图生物新发布《安图生物关于使用闲置募集资金进行现金管理赎回及进展的公告》
安图生物(603658)披露关于使用闲置募集资金进行现金管理赎回及进展的公告,8月17日股价下跌2.38%
证券之星 · 08-17
安图生物(603658)披露关于使用闲置募集资金进行现金管理赎回及进展的公告,8月17日股价下跌2.38%
股市必读:安图生物(603658)8月7日董秘有最新回复
证券之星 · 08-10
股市必读:安图生物(603658)8月7日董秘有最新回复
每周股票复盘:安图生物(603658)二级子公司注销医疗器械经营资质
证券之星 · 08-09
每周股票复盘:安图生物(603658)二级子公司注销医疗器械经营资质
安图生物:公司基于实际经营需求对人员规模的动态调整
证券之星 · 08-07
安图生物:公司基于实际经营需求对人员规模的动态调整
股市必读:安图生物新发布《安图生物关于二级子公司注销医疗器械经营许可证及第二类医疗器械经营备案凭证的公告》
证券之星 · 08-06
股市必读:安图生物新发布《安图生物关于二级子公司注销医疗器械经营许可证及第二类医疗器械经营备案凭证的公告》
安图生物(603658)披露二级子公司注销医疗器械经营许可及备案凭证公告,8月4日股价下跌1.79%
证券之星 · 08-04
安图生物(603658)披露二级子公司注销医疗器械经营许可及备案凭证公告,8月4日股价下跌1.79%
安图生物:公司将及时履行信息披露义务
证券之星 · 07-15
安图生物:公司将及时履行信息披露义务
每周股票复盘:安图生物(603658)子公司获医疗器械生产许可
证券之星 · 07-12
每周股票复盘:安图生物(603658)子公司获医疗器械生产许可
加载更多
公司概况
公司名称:
郑州安图生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-01
主营业务:
郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。
发行价格:
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":32.98,"timestamp":1788505201000,"preClose":32.39,"halted":0,"volume":2522930,"delay":0,"changeRate":0.0182,"floatShares":571000000,"shares":571000000,"eps":1.7398,"marketStatus":"已收盘","change":0.59,"latestTime":"09-04 15:00:00","open":32.88,"high":33.2,"low":32.26,"amount":82929000,"amplitude":0.029,"askPrice":32.99,"askSize":33,"bidPrice":32.98,"bidSize":316,"shortable":0,"etf":0,"ttmEps":1.7398,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":32.39,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":35.63,"lowLimit":29.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571424768,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":18.956202,"roe":"5.49%","epsLYR":1.87,"committee":0.68595,"marketValue":18846000000,"turnoverRate":0.0044,"status":0,"floatMarketCap":18846000000},"requestUrl":"/m/hq/s/603658","defaultTab":"news","newsList":[{"id":"2665936270","title":"股市必读:安图生物新发布《安图生物2026年第一次临时股东会会议材料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665936270?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:21","pubTimestamp":1788715269,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,上涨1.82%,换手率0.44%,成交量2.52万手,成交额8292.9万元。公司公告汇总:安图生物拟终止“体外诊断产品产能扩大项目”,将81,187.63万元剩余募集资金转投至“体外诊断产品研发中心项目”,并新增智慧化实验室产品开发内容及四家实施主体,相关事项尚需股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366887","title":"每周股票复盘:安图生物(603658)拟变更募投项目及公司经营范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366887?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:57","pubTimestamp":1788634628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,较上周的33.07元下跌0.27%。本周,安图生物9月2日盘中最高价报33.48元。安图生物当前最新总市值188.46亿元,在医疗器械板块市值排名13/129,在两市A股市值排名1032/5214。本周关注点来自公司公告汇总:安图生物拟终止“体外诊断产品产能扩大项目”,将剩余募集资金81,187.63万元转投至“体外诊断产品研发中心项目”。公司同时拟变更经营范围,增加通用设备制造、专用设备制造及机械设备销售,并修订《公司章程》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333468","title":"安图生物(603658)披露终止部分募投项目并调整募集资金用途,9月4日股价上涨1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333468","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664333468?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:41","pubTimestamp":1788514877,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,安图生物报收于32.98元,较前一交易日上涨1.82%,最新总市值为188.46亿元。该股当日开盘32.88元,最高33.2元,最低32.26元,成交额达8292.9万元,换手率为0.44%。近日,安图生物发布《2026年第一次临时股东会会议材料》公告。公司拟终止2020年非公开发行股票募投项目中的‘体外诊断产品产能扩大项目’,并将剩余募集资金81,187.63万元转投至‘体外诊断产品研发中心项目’。上述事项尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400031627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047074","title":"股市必读:安图生物新发布《安图生物关于公司及二级子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047074","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047074?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:26","pubTimestamp":1788128772,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,安图生物报收于33.07元,下跌1.34%,换手率0.39%,成交量2.24万手,成交额7421.24万元。当日关注点交易信息汇总:8月28日主力资金净流入768.12万元,占总成交额10.35%。公司公告汇总:安图生物及二级子公司郑州标源获5项医疗器械注册证,涵盖可溶性ST2蛋白检测等体外诊断相关产品,注册证有效期均为5年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1100","BK1574","BK1583","BK0239","159883","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048882","title":"每周股票复盘:安图生物(603658)股东户数降7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048882?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:50","pubTimestamp":1788036618,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,安图生物报收于33.07元,较上周的34.6元下跌4.42%。本周,安图生物8月24日盘中最高价报34.99元。股本股东变化股东户数变动截至2026年6月30日,安图生物股东户数为3.48万户,较3月31日减少2655户,减幅为7.09%。公司公告汇总安图生物2026年半年度报告摘要公司总资产为11,784,102,379.83元,较上年度末减少4.11%;归属于上市公司股东的净资产为8,674,379,764.28元,较上年度末减少2.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752633","title":"股市必读:安图生物中报 - 第二季度单季净利润同比下降13.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662752633?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:37","pubTimestamp":1787690230,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润4.97亿元,同比下降12.94%;第二季度单季度归母净利润2.61亿元,同比下降13.43%。业绩披露要点财务报告2026年中报显示,上半年度主营收入20.58亿元,同比下降0.12%;归母净利润4.97亿元,同比下降12.94%;扣非净利润4.93亿元,同比下降9.73%;第二季度单季度主营收入10.66亿元,同比上升0.13%;单季度归母净利润2.61亿元,同比下降13.43%;单季度扣非净利润2.61亿元,同比下降9.91%;负债率25.6%,投资收益2971.9万元,财务费用1715.65万元,毛利率67.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600008060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662385597","title":"安图生物(603658)6月30日股东户数3.48万户,较上期减少7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662385597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662385597?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:38","pubTimestamp":1787650713,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安图生物披露,截至2026年6月30日公司股东户数为3.48万户,较3月31日减少2655.0户,减幅为7.09%。在医疗器械行业个股中,安图生物股东户数高于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.13万户。从股价来看,2026年3月31日至2026年6月30日,安图生物区间跌幅为9.72%,在此期间股东户数减少2655.0户,减幅为7.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662783079","title":"国金证券:给予安图生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662783079","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662783079?lang=zh_cn&edition=full","pubTime":"2026-08-25 12:21","pubTimestamp":1787631715,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对安图生物进行研究并发布了研究报告《海外创新加速突破,拓展长期增长点》,给予安图生物买入评级。 盈利预测 预计公司2026-2028年归母净利润分别为10.16、11.38、13.55亿元,同比-5%、+12%、+19%,现价对应PE为19、17、14倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。本文数据来源于国金证券股份有限公司,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500024125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203384","title":"图解安图生物中报:第二季度单季净利润同比下降13.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203384?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:56","pubTimestamp":1787594162,"startTime":"0","endTime":"0","summary":"证券之星消息,安图生物2026年中报显示,上半年度公司主营收入20.58亿元,同比下降0.12%;归母净利润4.97亿元,同比下降12.94%;扣非净利润4.93亿元,同比下降9.73%;其中2026年第二季度,公司单季度主营收入10.66亿元,同比上升0.13%;单季度归母净利润2.61亿元,同比下降13.43%;单季度扣非净利润2.61亿元,同比下降9.91%;负债率25.6%,投资收益2971.9万元,财务费用1715.65万元,毛利率67.25%。财报数据概要请见下图:本文数据来源于安图生物2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027296","title":"安图生物(603658)披露2026年半年度报告,8月24日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661027296?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:37","pubTimestamp":1787582261,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,安图生物报收于34.08元,较前一交易日下跌1.5%,最新总市值为194.74亿元。该股当日开盘34.88元,最高34.99元,最低34.0元,成交额达1.23亿元,换手率为0.63%。近日,郑州安图生物工程股份有限公司披露2026年半年度报告摘要。公告显示,公司总资产为11,784,102,379.83元,较上年度末减少4.11%;归属于上市公司股东的净资产为8,674,379,764.28元,较上年度末减少2.82%。经营活动产生的现金流量净额为215,841,961.03元,较上年同期减少47.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661921462","title":"每周股票复盘:安图生物(603658)募集资金现金管理赎回17,298.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661921462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661921462?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:55","pubTimestamp":1787428509,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,安图生物报收于34.6元,较上周的33.67元上涨2.76%。本周,安图生物8月20日盘中最高价报35.49元。公司公告汇总安图生物使用2020年非公开发行股票的闲置募集资金16,000万元进行现金管理,购买可转让大额存单和券商收益凭证,产品期限不超过12个月,均为保本型产品,不影响募投项目实施。截至2026年8月17日,前期累计17,000万元大额存单已到期赎回,收回本金并取得利息收益共计17,298.08万元,款项已归还至募集资金专户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491270","title":"股市必读:安图生物新发布《安图生物关于使用闲置募集资金进行现金管理赎回及进展的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491270?lang=zh_cn&edition=full","pubTime":"2026-08-19 03:00","pubTimestamp":1787079638,"startTime":"0","endTime":"0","summary":"公司公告汇总:安图生物前期累计17,000万元闲置募集资金购买的大额存单已到期赎回,收回本息共计17,298.08万元并归还至募集资金专户。公司公告汇总安图生物关于使用闲置募集资金进行现金管理赎回及进展的公告郑州安图生物工程股份有限公司使用2020年非公开发行股票的闲置募集资金16,000万元进行现金管理,购买可转让大额存单和券商收益凭证,产品期限不超过12个月,均为保本型产品,不影响募投项目实施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900002031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660690435","title":"安图生物(603658)披露关于使用闲置募集资金进行现金管理赎回及进展的公告,8月17日股价下跌2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660690435","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660690435?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:29","pubTimestamp":1786976960,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘,安图生物报收于32.87元,较前一交易日下跌2.38%,最新总市值为187.83亿元。近日,安图生物发布《关于使用闲置募集资金进行现金管理赎回及进展的公告》。截至2026年8月17日,前期累计17,000万元大额存单已到期赎回,收回本金并取得利息收益共计17,298.08万元,已归还至募集资金专户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700035738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658608864","title":"股市必读:安图生物(603658)8月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658608864?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:08","pubTimestamp":1786298897,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,安图生物报收于32.43元,上涨1.31%,换手率0.63%,成交量3.62万手,成交额1.16亿元。董秘最新回复投资者: 体外诊断行业竞争日趋激烈,2025年公司人员规模有所收缩,人均营收同步回落。公司基于实际经营需求对人员规模的动态调整,是公司顺应整体业务发展的主动管理举措。当日关注点交易信息汇总:8月7日主力资金净流入407.74万元,占总成交额3.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675309","title":"每周股票复盘:安图生物(603658)二级子公司注销医疗器械经营资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658675309?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:34","pubTimestamp":1786214052,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,安图生物报收于32.43元,较上周的33.11元下跌2.05%。本周,安图生物8月3日盘中最高价报34.7元。8月7日盘中最低价报31.61元。安图生物当前最新总市值185.31亿元,在医疗器械板块市值排名13/129,在两市A股市值排名1059/5205。注销原因为业务结构优化与内部资源整合,不会对公司生产经营产生实质影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK0046","BK1100","603658","09996","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657861844","title":"安图生物:公司基于实际经营需求对人员规模的动态调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2657861844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657861844?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:37","pubTimestamp":1786088226,"startTime":"0","endTime":"0","summary":"证券之星消息,安图生物08月07日在投资者关系平台上答复投资者关心的问题。投资者提问:体外诊断行业竞争日趋激烈,2025年公司人员规模有所收缩,人均营收同步回落。公司基于实际经营需求对人员规模的动态调整,是公司顺应整体业务发展的主动管理举措。关于人力投入与人才培养部分,公司将按照监管要求在定期报告中依法合规披露,感谢您的相关建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700021347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657215515","title":"股市必读:安图生物新发布《安图生物关于二级子公司注销医疗器械经营许可证及第二类医疗器械经营备案凭证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657215515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657215515?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:27","pubTimestamp":1785950830,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,安图生物报收于32.66元,下跌2.68%,换手率0.74%,成交量4.2万手,成交额1.38亿元。当日关注点交易信息汇总:8月5日主力资金净流出721.7万元,占总成交额5.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0239","BK1100","BK1574","BK1583","09996","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552184","title":"安图生物(603658)披露二级子公司注销医疗器械经营许可及备案凭证公告,8月4日股价下跌1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656552184?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:29","pubTimestamp":1785853755,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,安图生物报收于33.56元,较前一交易日下跌1.79%,最新总市值为191.77亿元。近日,安图生物发布《关于二级子公司注销医疗器械经营许可证及第二类医疗器械经营备案凭证的公告》。公告显示,公司二级子公司郑州标源生物科技有限公司已向郑州经济技术开发区市场监督管理局提交医疗器械经营许可证及第二类医疗器械经营备案凭证的注销申请,并获得《准予行政许可决定书》,相关手续已办理完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0046","09996","BK0239","BK1574","603658","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651458797","title":"安图生物:公司将及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2651458797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651458797?lang=zh_cn&edition=full","pubTime":"2026-07-15 15:51","pubTimestamp":1784101878,"startTime":"0","endTime":"0","summary":"证券之星消息,安图生物07月15日在投资者关系平台上答复投资者关心的问题。公司管理层高度重视股东权益持续关注公司股价走势,如后续有相关具体安排,公司将严格按照法律法规要求,及时履行信息披露义务,敬请留意公司公告。公司管理层将全力做好生产经营,稳步提升公司核心价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500027783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154656","title":"每周股票复盘:安图生物(603658)子公司获医疗器械生产许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154656","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154656?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:19","pubTimestamp":1783793948,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,安图生物报收于30.78元,较上周的31.02元下跌0.77%。本周关注点来自公司公告汇总:安图实验仪器(郑州)有限公司取得《医疗器械生产许可证》,生产范围新增多项设备类别。来自公司公告汇总:安图生物及子公司获两项医疗器械注册证,涉及检验数据管理软件和白介素检测试剂盒。安图生物及全资子公司安图实验仪器(郑州)有限公司近日收到河南省药品监督管理局颁发的两项医疗器械注册证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK1100","159883","09996","BK1574","BK0239","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788722803333,"stockEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0098},{"period":"3month","weight":0.0605},{"period":"6month","weight":-0.0194},{"period":"1year","weight":-0.149},{"period":"ytd","weight":-0.031}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34787人(较上一季度减少7.09%)","perCapita":"16426股","listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","registeredCapital":"57142万元","survey":" 郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、质控品试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、血液学检测仪器、检验辅助仪器。","listedPrice":14.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}